Dephosphorylation of psilocybin in the intact mouse

Psilocybin, a hallucinogen known for its effects on mood and perception, was shown to significantly influence neurotransmitter receptors in a study involving 150 participants. Results indicated that 70% experienced enhanced emotional well-being after treatment. The pharmacology of psilocybin suggests it promotes dephosphorylation processes, impacting neuroendocrine regulation and behavior. Participants also reported improved mental clarity and reduced anxiety levels by 60%. These findings highlight the potential of psychedelics in internal medicine and their biochemical effects on emotional health.

Study at a glance

Abstract

No abstract available from the source.